Blue Gene Project Takes First Steps to Answer Protein Folding s Big Questions | GenomeWeb

A year and three months into the Blue Gene protein folding project, IBM researchers said they have made some noteworthy progress in addressing several fundamental issues posed by the monumental effort.

The daunting scale of the supercomputer, which will link an unprecedented one million processors into a one-petaflop system, as well as the algorithmic challenges presented by protein-folding simulation, have led the IBM team to explore new territory in both the hardware and the software side of the equation.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.